Cargando…
Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer
BACKGROUND: Interleukin-27 (IL-27) has been recognized as a pleiotropic cytokine with both pro- and anti-inflammatory properties. Few studies have investigated polymorphisms and serum/plasma levels of IL-27 in diseases including cancers. This study has analyzed the associations of IL-27 gene polymor...
Autores principales: | Zhou, Bin, Zhang, Peng, Tang, Tielong, Liao, Hong, Zhang, Kui, Pu, Yan, Chen, Peng, Song, Yaping, Zhang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445811/ https://www.ncbi.nlm.nih.gov/pubmed/26014498 http://dx.doi.org/10.1186/s12885-015-1459-7 |
Ejemplares similares
-
Associations of IL-27 Polymorphisms and Serum IL-27p28 Levels With Osteosarcoma Risk
por: Tang, Yu-jin, et al.
Publicado: (2014) -
Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer
por: Zhang, Kui, et al.
Publicado: (2014) -
Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level
por: Barac, Ioana S., et al.
Publicado: (2021) -
Contribution of activated platelets to plasma IL-27 levels
por: Hamzeh-Cognasse, Hind, et al.
Publicado: (2013) -
Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis
por: Peng, Xingchun, et al.
Publicado: (2018)